Lilly Wins Short Ban On Generic Strattera

Law360, New York (August 19, 2010, 4:44 PM EDT) -- A federal judge has ruled that generics makers may not launch their own versions of Eli Lilly & Co.'s Strattera in the U.S. for two weeks following the entry of a final judgment in a patent spat over the attention deficit hyperactivity disorder drug, shooting down Lilly's request for a longer reprieve.

In a ruling Wednesday, Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey enjoined the defendants for the 14-day period in order to allow Lilly to try to...
To view the full article, register now.